전남대학교 중앙도서관

Performance of the GenoType MTBDRsl in a programmatic setting, South Africa

학술저널

issue: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE; MAY 1 2022, 26 5, p426-p432, 7p.
Author: Lutchminarain, K.
Kajee, A.
Gandhi, N. R.
Han, K. S. S.
Mvelase, N.
DB Label: Database : Science Citation Index Expanded

원문보기: 등재 - Web of Science 등재 - SCOPUS 조회 - Impact Factor (JCR)

Baseline and Emergent Bedaquiline Resistance Associated with Poor Outcomes in Drug-Resistant Tuberculosis

학술저널

issue: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE; 2020, 201 2p.
Author: Nimmo, C.
Millard, J.
Brien, K.
Moodley, S.
van Dorp, L.
Lutchminarain, K.
Wolf, A.
Grant, A.
Balloux, F.
Pym, A. S.
O'Donnell, M. R.
DB Label: Database : Science Citation Index Expanded

원문보기: 등재 - Web of Science 등재 - SCOPUS 조회 - Impact Factor (JCR)

Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).

학술저널

issue: PLoS medicine [PLoS Med] 2023 May 22; Vol. 20 (5), pp. e1004237. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023).
Author: Martinson NA; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.; Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America.
Nonyane BAS; Johns Hopkins Bloomberg School of Public Health, Department of International Health, Baltimore, Maryland, United States of America.
Genade LP; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.
Berhanu RH; Department of Medicine, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Naidoo P; Public Health Management Consultant, South Africa, Johannesburg, South Africa.
Brey Z; Bill and Melinda Gates Foundation, South Africa, Johannesburg, South Africa.
Kinghorn A; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.
Nyathi S; AQUITY Innovations, Centurion, South Africa.
Young K; TB HIV Care, Cape Town, South Africa.
Hausler H; TB HIV Care, Cape Town, South Africa.
Connell L; Right to Care, Centurion, South Africa.
Lutchminarain K; National Health Laboratory Service Department of Microbiology, Inkosi Albert Luthuli Central Hospital, eThekwini, South Africa.; University of Kwa Zulu Natal, Durban, South Africa.
Swe Swe-Han K; National Health Laboratory Service Department of Microbiology, Inkosi Albert Luthuli Central Hospital, eThekwini, South Africa.; University of Kwa Zulu Natal, Durban, South Africa.
Vreede H; National Health Laboratory Service, Chemical Pathology, Groote Schuur Hospital, Cape Town, South Africa.
Said M; National Health Laboratory Service, Microbiology and Academic Division, Tshwane, South Africa.; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
von Knorring N; National Health Laboratory Service, Clinical Microbiology, Johannesburg, South Africa.; Division of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand, Johannesburg, South Africa.
Moulton LH; Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America.
Lebina L; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.; Africa Health Research Institute, KwaZulu Natal, South Africa.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients.

보고서

issue: The European respiratory journal [Eur Respir J] 2020 Jun 04; Vol. 55 (6). Date of Electronic Publication: 2020 Jun 04 (Print Publication: 2020).
Author: Nimmo C; Division of Infection and Immunity, University College London, London, UK.; UCL Genetics Institute, University College London, London, UK.; Africa Health Research Institute, Durban, South Africa.
Millard J; Africa Health Research Institute, Durban, South Africa.; Wellcome Trust Liverpool Glasgow Centre for Global Health Research, Liverpool, UK.; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Brien K; Africa Health Research Institute, Durban, South Africa.
Moodley S; Africa Health Research Institute, Durban, South Africa.
van Dorp L; UCL Genetics Institute, University College London, London, UK.
Lutchminarain K; National Health Laboratory Service, Durban, South Africa.
Wolf A; Dept of Medicine, Columbia University Medical Center, New York, NY, USA.
Grant AD; Africa Health Research Institute, Durban, South Africa.; TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
Balloux F; UCL Genetics Institute, University College London, London, UK.
Pym AS; Africa Health Research Institute, Durban, South Africa.
Padayatchi N; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
O'Donnell M; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa mo2130@cumc.columbia.edu.; Dept of Medicine and Epidemiology, Columbia University Medical Center, New York, NY, USA.
DB Label: Database : MEDLINE

원문보기: Full Text(ECC) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.

학술저널